vimarsana.com
Home
Live Updates
Dragonfly Therapeutics Initiates Phase 1 1b Study of its IL-
Dragonfly Therapeutics Initiates Phase 1 1b Study of its IL-
Dragonfly Therapeutics Initiates Phase 1 1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors
The company announces the first patient dosed in a Phase 1/1b clinical trial evaluating its novel IL-2 cytokine, DF6215, the seventh Dragonfly-developed drug ...
Related Keywords
,
Prnewswire Dragonfly Therapeutics Inc ,
Altre News ,
Therapeutics Initiates Phase ,
Advanced Solid Tumors ,
Dragonfly Therapeutics ,
Solid Tumor ,
Dragonfly ,
Herapeutics ,
Nitiates ,
Hase ,
Study ,
Its ,
Immunotherapy ,
Patients ,
Ith ,
Dvanced ,
Olid ,
Rumors ,